For Align Technology (ALGN) , we remain concerned about the current economic uncertainty, which continues to cast a negative impact on the company’s dental procedures. The competitive landscape also remains an overhang. The stock carries a Zacks Rank #4 (Sell) currently.Factors Dragging ALGN Shares DownIn recent times, Align Technology has faced a decline in Invisalign's average selling price (ASP) for comprehensive treatment options. This resulted in a decrease in the company’s revenues. In the second quar ...

The early weeks of January are a wonderful time to reshuffle your stock portfolio and buy great stocks with big long-term upside. The bull case remains firmly in place even after the stock market’s best back-to-back years since the late 1990s.That said, the market appears a tad overheated heading into Q4 earnings season next week. There could be some selling pressure to recalibrate valuations and take some of the foam off the top of the market.Despite tech and broader market valuations looking a bit stretch ...

Leerink Partners upgraded Align Technology Inc ALGN, citing upside opportunities throughout 2025 given gross margin expansion opportunities.Align Technology — a medical device company that manufactures and sells dental aligners, scanners, and software for digital orthodontics and restorative dentistry — will benefit from improving consumer sentiment, easing comps and continued equipment traction with Lumina.In October, Align Technology announced that it is planning to repurchase $275 million of its common s ...

Company Performance - Shares of Align Technology (NASDAQ: ALGN), the market leader in clear aligners, have fallen more than 20% over the past year due to slowing growth in a tough macroeconomic environment where discretionary spending by consumers has been impacted [1] Analyst Background - The analyst is an individual investor with a focus on undercovered companies, particularly in technology, software, electronics, and the energy transition sectors [1] - The analyst has over 7 years of personal investing experience and a Masters degree in Electrical Engineering, currently working as an automotive battery R&D engineer in Sweden [1] - The analyst enjoys researching small to mid-cap companies that are often less covered by others, aiming to identify asymmetric investment opportunities for market-beating returns [1]

Core Insights - Align Technologies is well-positioned for growth due to the robust potential of Invisalign and strategic expansions [1][3] - The company has a market capitalization of $15.94 billion and has consistently surpassed earnings estimates [2] - The malocclusion market presents a significant opportunity for Align Technologies, with only 22 million people globally opting for orthodontic treatment annually, indicating a large untapped patient base [3] Financial Performance - In the third quarter, Align Technologies reported a 15.6% increase in Systems and Services revenues, driven by higher scanner average selling prices (ASPs) and increased service revenues [6] - Clear Aligner volume reached 617,000, reflecting a 2.5% year-over-year increase, with growth noted across all regions [12] - The Zacks Consensus Estimate for the company's 2024 revenues is projected at $4.04 billion, suggesting a 4.6% increase from the previous year [17] Market Dynamics - The company faces macroeconomic challenges, including staffing shortages and supply chain issues, which are impacting revenues and margins [7] - Adverse currency impacts are a concern, particularly due to a significant portion of revenues coming from international markets, affecting Clear Aligner ASPs [16] Strategic Initiatives - Align Technologies is focusing on strategic alliances with dental support organizations (DSOs) to drive the adoption of digital dentistry, particularly targeting young adults and teens through influencer partnerships [13] - The iTero intraoral scanners and exocad CAD/CAM software are expanding their market presence, with the launch of the next-generation iTero Lumina scanner [14]

Align Technology's (ALGN) dental procedures continue to be affected by the current economic uncertainty. The competitive landscape also remains an overhang. The stock carries a Zacks Rank #4 (Sell) currently.Factors Dragging ALGN Shares DownThe ongoing industry-wide trend of staffing shortages and supply chain-related hazards is denting revenues and margins for Align Technology. Deteriorating international trade, with global inflationary pressure leading to a tough situation related to raw material and labo ...

It has been about a month since the last earnings report for Align Technology (ALGN) . Shares have added about 5.5% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Align Technology due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers. Align Technology's Q3 Earnings Top Es ...

Align Technologies (ALGN) has received a CE Mark in Europe under the Medical Device Regulation (MDR 2017/745) for its Invisalign Palatal Expander System. The system has completed registration with MHRA for the United Kingdom and overseas territories.The latest developments mark a milestone in the company’s efforts to enhance clinical outcomes and efficiency in orthodontics. Both approvals are for broad patient applicability, including growing children, teens and adults (with surgery or other techniques).ALG ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________ FORM 10-Q ____________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to | --- | --- | --- | |----------------------------------------------------------------|------- ...

Align Technology, Inc. (ALGN) recently announced the release of the next version of Invisalign Smile Architect software. The software now supports Multiple Treatment Plans, which is likely to allow doctors to visually compare and modify orthodontic only and ortho restorative treatment plans side-by-side. The Multiple Treatment Plans are integrated into ClinCheck treatment planning software which allows doctors to visually compare, review, and choose the best treatment option for each patient. Likely Trend o ...